Metraipolis › archive › dc_211ee1dd2a44
Incidence and risk of hypertension and proteinuria in cancer patients treated with lenvatinib: a systematic review and meta-analysis — Europe PMC PMID:40632590
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40632590
- DOI
- 10.1093/oncolo/oyaf203
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:17:00.104Z
- SHA-256 of the archived text
ac6561f1d545fdc1d219488ccaa6a909cc4e936454662c800a302d8cfb2e047b- Stable URL of this page
https://metraipolis.com/documento/dc_211ee1dd2a44
How to cite
Incidence and risk of hypertension and proteinuria in cancer patients treated with lenvatinib: a systematic review and meta-analysis — Europe PMC PMID:40632590 — Europe PMC (en), https://europepmc.org/article/MED/40632590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_211ee1dd2a44 (Metraipolis archive dc_211ee1dd2a44, sha256 ac6561f1d545fdc1d219488ccaa6a909cc4e936454662c800a302d8cfb2e047b)
BibTeX
@misc{dc211ee1dd2a44,
title = {Incidence and risk of hypertension and proteinuria in cancer patients treated with lenvatinib: a systematic review and meta-analysis — Europe PMC PMID:40632590},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40632590},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_211ee1dd2a44; sha256 ac6561f1d545fdc1d219488ccaa6a909cc4e936454662c800a302d8cfb2e047b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40632590. Agents can read the archived copy with the MCP tool read_document.